Omnicell (OMCL) Competitors

Omnicell (NASDAQ:OMCL) and HealthStream (NASDAQ:HSTM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, community ranking, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

Is OMCL or HSTM more profitable?

HealthStream has a net margin of 6.84% compared to Omnicell's net margin of 1.13%. HealthStream's return on equity of 5.67% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	1.13%	3.82%	2.07%
HealthStream	6.84%	5.67%	3.91%

Do institutionals & insiders hold more shares of OMCL or HSTM?

97.7% of Omnicell shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 2.6% of Omnicell shares are owned by insiders. Comparatively, 20.6% of HealthStream shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Do analysts rate OMCL or HSTM?

Omnicell currently has a consensus target price of $52.33, suggesting a potential upside of 31.76%. HealthStream has a consensus target price of $31.50, suggesting a potential downside of 4.20%. Given Omnicell's higher probable upside, equities analysts clearly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
HealthStream	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Does the media prefer OMCL or HSTM?

In the previous week, Omnicell had 2 more articles in the media than HealthStream. MarketBeat recorded 7 mentions for Omnicell and 5 mentions for HealthStream. Omnicell's average media sentiment score of 0.93 beat HealthStream's score of 0.90 indicating that Omnicell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer OMCL or HSTM?

Omnicell received 38 more outperform votes than HealthStream when rated by MarketBeat users. Likewise, 66.93% of users gave Omnicell an outperform vote while only 66.57% of users gave HealthStream an outperform vote.

Company	Underperform	Outperform
Omnicell	Outperform Votes 500 66.93%	Underperform Votes 247 33.07%
HealthStream	Outperform Votes 462 66.57%	Underperform Votes 232 33.43%

Which has preferable valuation and earnings, OMCL or HSTM?

HealthStream has lower revenue, but higher earnings than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.11B	1.65	$12.53M	$0.27	147.12
HealthStream	$279.06M	3.58	$15.21M	$0.65	50.59

Which has more volatility and risk, OMCL or HSTM?

Omnicell has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 0.39, suggesting that its stock price is 61% less volatile than the S&P 500.

Summary

Omnicell beats HealthStream on 10 of the 19 factors compared between the two stocks.